See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
There is no publicly available rating for this medical professional for one of the following reasons:
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
My clinical expertise is in GU pathology.
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
Application of high through-put technology to gain insights into the biology of human cancers, with special interest in GU cancers.
Aileen Grace P. Arriola, Sahar J. Farahani, Hersh K. Bhargava, Thomas J. Guzzo, John S.J. Brooks and Priti Lal: PDL-1 Expression reveals significant association with squamous differentiation in Upper Tract Urothelial Carcinoma AJCP : 2019 .
Sam Sadig, Sahar Farhani, Abhishekh Shah, David Vaughn, Priti Lal: Differences in PD-L1 Expressing Macrophages and Immune Micro-environment in Testicular Germ Cell Tumors American Journal of Clinical Pathology 153 (3): 387-395,2020.
Hersh K. Bhargava, Patrick Leo, Robin Elliott, Andrew Janowczyk, Jon Whitney, Sanjay Gupta4, Pingfu Fu, Kosj Yamoah, Francesca Khani, Brian D. Robinson, Timothy R. Rebbeck, Michael D. Feldman1, Priti Lal, Anant Madabhushi: Computationally derived image signature of stromal morphology is prognostic of prostate cancer recurrence following prostatectomy in African American patients Clinical Cancer Research 26 (8): 1915,2020.
Narayan V, Hwang WT, Lal P, Rosen MA, Gallagher M, O'Dwyer PJ, Vaughn DJ: Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Unresectable Mature Teratoma: Long-Term Follow-Up of a Phase II Study. Clin Genitourin Cancer
PMID: 27055371 : 2016.
Charnita Zeigler Johnson, Michael Feldman, Priti Lal, et al: The relationship between Obesity, Prostate Tumor Infiltrating Lymphocytes and Macrophages, and Biochemical Failure. PLOS ONE : 2016.
Rasool RU, Natesan R, Deng Q, Aras S, Lal P, Sander Effron S, Mitchell-Velasquez E, Posimo JM, Carskadon S, Baca SC, Pomerantz MM, Siddiqui J5, Schwartz LE, Lee DJ, Palanisamy N, Narla G, Den RB, Freedman ML, Brady DC, Asangani IA: CDK7 inhibition suppresses Castration- Resistant Prostate Cancer through MED1 inactivaion Cancer Discovery : 2019.
Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal P, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, Schaeffer EM.: Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.
J Clin Oncol. : 2015.
Jenkins TM, Rosenbaum J, Zhang PJ, Schwartz LE, Nayak A, Cooper K, Tickoo SK, Lal P.: Thyroid-Like Follicular Carcinoma of the Kidney with Extensive Sarcomatoid Differentiation: A Case Report and Review of the Literature International journal of surgical pathology 27 (6): 678-683,2019.
Hersh Bhargava, Patrick Leo, Robin Elliott, Andrew Janowczyk, Jon Whitney, Sanjay Gupta, Pingfu Fu, Kosj Yamoah, Timothy Rebbeck, Michael Feldman, Priti Lal, and Anant Madabhushi: Digital features of stromal morphology in prostate cancer differ between African-Americans and Caucasians and are prognostic of recurrence following prostatectomy Clinical cancer Research : 2018.
Vivek Narayan, Naomi Haas, Priti Lal et al: A Phase 1 Clinical Trial of PSMA-directed/TGFβ-insensitive CAR-T cells in Metastatic Castration-Resistant Prostate Cancer ASCO 2020 : 2020.
Rachana Garg, Jorge M Blando, Carlos J Perez, Priti Lal, Michael D Feldman, Emer M Smyth, Emanuela Ricciotti, Tilo Grosser, Fernando Benavides, Marcelo G Kazanietz: COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer Oncogene 37 (34): 2018.
Department of Pathology and Laboratory MedicineHospital of the University of Pennsylvania6 Founders Pavilion 3400 Spruce Street